Dr. Myers Ronald E. Myers, DSW, Ph.D.

Contact Dr. Myers

1025 Walnut Street
Suite 1014
Philadelphia, PA 19107

(215) 503-4085
(215) 503-9506 fax

Education
B.S., Shippensburg University, History, 1972
M.S., Shippensburg University, Counseling, 1977
DSW, University of Pennsylvania, School of Social Work, 1983
Ph.D., University of Pennsylvania, Sociology, 1989

University Appointment
Director: Kimmel Cancer Center Cancer Prevention & Control
Appointed: 1997

Director: Department of Medical Oncology, Division of Population Science
Professor Appointed: 2001

Professor: Department of Psychiatry & Human Behavior Appointed: 2001

Research and Clinical Interests
Dr. Ronald E. Myers received a D.S.W. in Social Welfare Policy in 1983 and a Ph.D. in Medical Sociology in 1989 from the University of Pennsylvania.

In addition, Dr. Myers completed postdoctoral training in Behavioral Epidemiology at Fox Chase Cancer Center from 1983 to 1985. Dr. Myers conducted cancer prevention and control research in the Division of Cancer Control and Population Sciences at Fox Chase Cancer Center in Philadelphia from 1985 to 1994. In 1994, Dr. Myers joined the Kimmel Cancer Center at Thomas Jefferson University and established a Cancer Prevention and Control Program. In 2001, Dr. Myers was appointed Professor of Medicine, Department of Medicine, Division of Genetic and Preventive Medicine, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA. Dr. Myers has conducted cancer prevention, control, and population science research for over 20 years. He has been a principal investigator on a number of NIH-funded research grants and has numerous peer-reviewed publications in the field. His areas of expertise include patient adherence to cancer screening; physician follow-up of abnormal cancer screening test results; and informed and shared decision making in cancer screening, susceptibility testing and clinical trials participation. Currently, Dr. Myers leads a special populations project funded by the NCI Center for Reducing Cancer Health Disparities.

Publications

Most recent Peer-reviewed Publications

  1. Preoperative Platelet Count Associates with Survival and Distant Metastasis in Surgically Resected Colorectal Cancer Patients
  2. A randomized controlled trial of a tailored navigation and a standard intervention in colorectal cancer screening
  3. Genetic variations in stem cell-related genes and colorectal cancer prognosis
  4. Variation in Colorectal Cancer Screening Steps in Primary Care: Basis for Practice Improvement
  5. Automated telephone calls to enhance colorectal cancer screening: Economic analysis
  6. Comprehensive Analysis of Common Serum Liver Enzymes as Prospective Predictors of Hepatocellular Carcinoma in HBV Patients
  7. Predictive value of alpha-fetoprotein in the long-term risk of developing hepatocellular carcinoma in patients with hepatitis B virus infection - Results from a clinic-based longitudinal cohort
  8. Telomere length in circulating serum DNA as a novel non-invasive biomarker for cirrhosis: A nested case-control analysis
  9. International colorectal cancer screening programs: Population contact strategies, testing methods and screening rates
  10. Preferences for colorectal cancer screening tests and screening test use in a large multispecialty primary care practice
  11. Relative telomere length: A novel non-invasive biomarker for the risk of non-cirrhotic hepatocellular carcinoma in patients with chronic hepatitis B infection
  12. Genetic polymorphism in a vegf-independent angiogenesis gene angpt1 and overall survival of colorectal cancer patients after surgical resection
  13. Measuring informed decision making about prostate cancer screening in primary care
  14. Potentially functional genetic variants in KDR gene as prognostic markers in patients with resected colorectal cancer
  15. Primary care colorectal cancer screening recommendation patterns: Associated factors and screening outcomes
  16. Genetic polymorphisms in pre-microRNA genes as prognostic markers of colorectal cancer
  17. Screening for prostate cancer: the current evidence and guidelines controversy.
  18. GWAS-identified colorectal cancer susceptibility locus associates with disease prognosis
  19. A randomized controlled trial of a tailored interactive computer-delivered intervention to promote colorectal cancer screening: Sometimes more is just the same
  20. Reactions to a targeted intervention to increase fecal occult blood testing among average-risk adults waiting for screening colonoscopy

View All Publications